A UK-wide hospital pilot has paved the way for full NHS access to Abbott and Insulet’s latest diabetes management system for anyone who qualifies for
Abbott has announced that they are partnering with Medtronic Diabetes to connect a continuous glucose monitor (CGM) based on Abbott’s FreeStyle Libre tech with their
New research has found that adult patients with poorly controlled Type 1 diabetes on insulin pumps and continuous glucose monitoring (CGM) systems could benefit from
Medicare will start covering Senseonics’ implantable continuous glucose monitor (CGM) for a broader group of patients from late February. Last year, Medicare updated its policy
Dexcom has announced that it has launched the Dexcom ONE+ continuous glucose monitor (CGM) in the UK. Dexcom ONE+ uses Dexcom’s established sensor design, with
Abbott has received clearance from the Food and Drug Administration in the USA for an over-the-counter (OTC) glucose monitor. The device, called Lingo, first debuted
CamDiab has received authorisation from the Food and Drug Administration (FDA) in the US for its advanced adaptive hybrid closed-loop app, CamAPS FX, as an
Dexcom have announced that their Dexcom G7 continuous glucose monitoring (CGM) system is now capable of connecting directly to Apple Watch. The connection is made
The US Food and Drug Administration (FDA) has designated the Eversense (Senseonics, Inc; Ascencia Diabetes Care) implanted continuous glucose monitor (CGM) as an ‘integrated CGM,’
According to Drug Delivery Business, industry analysts are surprised at the increase in users of CGM within the non-insulin and basal insulin populations. William Blair
